Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Leoncini

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Journal of Clinical Pathology|March 16, 2002
Hodgkin's lymphoma: the pathologist's viewpointS A Pileri, S Ascani, L Leoncini, et al.
ESMO Open|February 4, 2021
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor BoardsR Danesi, S Fogli, S Indraccolo, et al.
Infectious Agents and Cancer|November 18, 2022
EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negativeM C Siciliano, S Tornambè, G Cevenini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2006
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian familyF Roviello, G Corso, C Pedrazzani, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
International Journal of Cancer|September 2, 1999
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysisL Leoncini, A Cossu, T Megha, et al.
International Journal of Cancer|July 15, 1998
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1L Leoncini, T Megha, S Lazzi, et al.
The Journal of Pathology|September 20, 2008
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulationE Leucci, M Cocco, A Onnis, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
The American Journal of Pathology|March 7, 2000
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypesC Cinti, L Leoncini, A Nyongo, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pathology|March 16, 2002
Hodgkin's lymphoma: the pathologist's viewpointS A Pileri, S Ascani, L Leoncini, et al.
ESMO Open|February 4, 2021
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor BoardsR Danesi, S Fogli, S Indraccolo, et al.
Infectious Agents and Cancer|November 18, 2022
EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negativeM C Siciliano, S Tornambè, G Cevenini, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2006
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian familyF Roviello, G Corso, C Pedrazzani, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
International Journal of Cancer|September 2, 1999
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysisL Leoncini, A Cossu, T Megha, et al.
International Journal of Cancer|July 15, 1998
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1L Leoncini, T Megha, S Lazzi, et al.
The Journal of Pathology|September 20, 2008
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulationE Leucci, M Cocco, A Onnis, et al.
The American Journal of Pathology|December 1, 1996
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissuesM Gambacorta, L Flenghi, M Fagioli, et al.
The American Journal of Pathology|March 7, 2000
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypesC Cinti, L Leoncini, A Nyongo, et al.
Pageof 14